The recent study found the addition of microbiome analysis helped identify high-risk patients, who should undergo colonoscopy screening. The study’s authors concluded that microbiome analysis should be used in conjunction with FOBT, rather than as a replacement.
More articles on gastroenterology:
Financial leadership playbook: The essential skills for a CFO in gastroenterology
Higher Medicaid reimbursement associated with higher cancer screening rates
The biggest threats to success in the GI field
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
